SCHEMBL8328204

SCHEMBL8328204

CC(C)(C)OC(=O)CN1CCN(CCNC(=O)CN2CCN(CC(=O)OC(C)(C)C)CCN(CC(=O)OC(C)(C)C)CCN(CC(=O)OC(C)(C)C)CC2)CCN(CC(=O)OC(C)(C)C)CCN(CC(=O)OC(C)(C)C)CC1

nearest known ligand 0.54

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CACNA1H O95180 5/20 0.54
SIGMAR1 Q99720 3/20 0.47
ALDH1A1 P00352 5/20 0.45
DRD2 P14416 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
CYP2D6 P10635 1/20 0.43
KCNH2 Q12809 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
POLB P06746 1/20 0.40
KMT2A Q03164 1/20 0.39
TP53 P04637 1/20 0.39
ACKR3 P25106 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7130844 0.92 ALDH1A1 (0.53) CACNA1HSIGMAR1ALDH1A1TDP1SMN1; SMN2
SCHEMBL25917727 0.88 SIGMAR1 (0.47) CACNA1HSIGMAR1ALDH1A1TDP1SMN1; SMN2
SCHEMBL6230689 0.87 SIGMAR1 (0.46) CACNA1HSIGMAR1ALDH1A1TDP1SMN1; SMN2
SCHEMBL8183645 0.86 SIGMAR1 (0.43) CACNA1HSIGMAR1ALDH1A1TDP1SMN1; SMN2
SCHEMBL15802919 0.85 ALDH1A1 (0.46) CACNA1HSIGMAR1ALDH1A1TDP1SMN1; SMN2
SCHEMBL7136069 0.85 ALDH1A1 (0.48) CACNA1HSIGMAR1ALDH1A1TDP1SMN1; SMN2
SCHEMBL31399675 0.85 SIGMAR1 (0.44) CACNA1HSIGMAR1ALDH1A1TDP1SMN1; SMN2
SCHEMBL14289006 0.84 SIGMAR1 (0.42) CACNA1HSIGMAR1ALDH1A1TDP1SMN1; SMN2
SCHEMBL15766907 0.84 AKT1 (0.44) CACNA1HSIGMAR1ALDH1A1DRD2TDP1
SCHEMBL15362895 0.84 AKT1 (0.44) CACNA1HSIGMAR1ALDH1A1DRD2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972307-A ADMINISTERING TO HUMAN OR ANIMAL BODY AN EFFECTIVE AMOUNT OF A DIAGNOSTIC AGENT COMPRISES A METAL CHELATE OF A COMPOUND HAVING TWO MACROCYCLIC CHELANT GROUPS LINKED BY A BRIDGE CONTAINING ESTER OR AMIDE BOND NYCOMED SALUTAR, INC. (US) 1999-10-26 US disclosed
US-5650133-A CHELATING AGENTS USEFUL IN DIAGNOSTIC AND THERAPEUTIC COMPOSITIONS NYCOMED SALUTAR (US) 1997-07-22 US disclosed
WO-1995009848-A2 POLYAZACYCLOALKANES AS DICHELANTS NYCOMED SALUTAR, INC. (US) 1995-04-13 WO disclosed